Retatrutide 10mg Snap Pen

Retatrutide is an investigational peptide therapy designed to activate three critical metabolic receptors—GLP-1, GIP, and glucagon. This triple agonist approach mimics and amplifies the body’s natural metabolic signals, resulting in profound effects on fat loss, blood sugar regulation, liver health, and inflammation.

What sets Retatrutide apart is its multi-hormone mechanism, which doesn’t just suppress appetite but also increases energy expenditure, reduces visceral and liver fat, and improves overall cardiometabolic function. In clinical trials, Retatrutide has achieved some of the highest weight loss outcomes ever recorded for a non-surgical treatment, while also addressing underlying drivers of metabolic disease.

Retatrutide is a multi-receptor agonist, meaning it activates three hormone pathways simultaneously:
GLP-1 (Glucagon-like Peptide-1): Promotes satiety, slows gastric emptying, and enhances glucose-stimulated insulin secretion.
GIP (Glucose-dependent Insulinotropic Polypeptide): Enhances insulin release in response to meals and synergizes with GLP-1 to improve metabolic response.
Glucagon Receptor: Stimulates fat oxidation, increases energy expenditure, and reduces liver fat stores. 

Together, these pathways reshape the body’s energy balance, reduce food intake, burn fat stores, and improve metabolic biomarkers more effectively than single-pathway drugs.